top of page
it's where dermatology lives
Pembrolizumab reduced recurrence risk of stage 3 melanoma
After a median follow-up of 15 months, 135 of the 514 patients treated with pembrolizumab
and 216 of the 505 patients treated with placebo
by Bianca Quijano
Apr 16, 20182 min read
Indoor tanning may provoke dependence, study shows
A study of a community sample of 389 non-Hispanic Caucasian young adult women aged 18 to 30 years, who had tanned indoors at least once in t
by John Evans
Dec 1, 20172 min read
Featured Posts
bottom of page